| VRCA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VRCA shares outstanding history going back to 6/15/2018:
Also see: VRCA Market Cap History VRCA YTD Return |
VRCA Shares Outstanding History — Verrica Pharmaceuticals Share Count Over Time
As of 5/5/2026 Verrica Pharmaceuticals has 17.18 million VRCA shares outstanding. Investors often track the VRCA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows VRCA share count trends over time, with 33 historical shares outstanding datapoints presented, dating back to 6/15/2018.
| VRCA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VRCA Historical Shares Outstanding: +27.69% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| VRCA Stock Price Chart |
| About Verrica Pharmaceuticals Inc |
| Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. Co. is focused on developing and commercializing treatments for skin diseases. Its product pipeline consists of three product candidates: YCANTH, VP-315 and VP-103. YCANTH is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin. Co. are also developing YCANTH for potential follow-on indications for the treatment of common warts and external genital warts. In addition, the Co. is also developing YCANTH for the treatment of external genital warts, or external genital warts EGW. We show 33 historical shares outstanding datapoints in our coverage of VRCA's shares outstanding history. Understanding the changing numbers of VRCA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VRCA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VRCA by allowing them to research VRCA shares outstanding history as well as any other stock in our coverage universe. |
| VRCA Current Stock Quote |
Quotes delayed 20 minutes  Free VRCA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| VRCA Share Performance |
| Shares Outstanding Peers |
| Verrica Pharmaceuticals (VRCA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
VRDN Shares Outstanding History VREX Shares Outstanding History VRML Shares Outstanding History VRPX Shares Outstanding History VRTX Shares Outstanding History VRX Shares Outstanding History VSAR Shares Outstanding History VSTM Shares Outstanding History VTGN Shares Outstanding History VTL Shares Outstanding History More Healthcare companies » |
VRCA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
